Skip to Content
Home > Services > Heart & Vascular > Cardiovascular Clinical Trials > Clinical Trials Search Results
This study is to demonstrate the safety and efficacy profile, in two different dose regimens of Edoxaban (DU-176b), (an investigational new drug being tested for the prevention of stroke/systemic embolic events (SEE)), in individuals with atrial fibrillation.
Send Us Your Questions, Comments or Feedback.
Awards & Certifications
Follow Us Online
©2014 Cone Health ~ Greensboro, NC